Edward W. Scott

Edward W. Scott

Auto-generated profile, based on publicly available information

Edward W. Scott

Program in Stem Cell Biology and Regenerative Medicine, Department of Molecular Genetics and Microbiology, College of Medicine, University of Florida, Gainesville, FL 32611, USA

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 August 2014 in Blood
Verified
Journal Article
Open access
PDF file
DLDavid Lopez
David Lopez
LLLi Lin
Li Lin
JMJames R. Monaghan
James R. Monaghan
Christopher CogleChristopher Cogle
Christopher Cogle
FBFrank J. Bova
Frank J. Bova
ESEdward W. Scott
Edward W. Scott
Key Points: Establishing HSC transplantation and assay methods for the axolotl. Axolotl sites of hematopoiesis are the spleen and liver.

1 May 2006 in Investigative Ophthalmology & Visual Science
Verified
Journal Article
Closed access
PDF file
JHJeffrey R. Harris
Jeffrey R. Harris
GBGary A. J. Brown
Gary A. J. Brown
MJMarda Jorgensen
Marda Jorgensen
SKShalesh Kaushal
Shalesh Kaushal
EEE. Ann Ellis
E. Ann Ellis
ESEdward W. Scott
Edward W. Scott
Purpose. To determine whether hematopoietic stem and progenitor cells (HSCs/HPCs) can home to and regenerate the retinal pigment epithelium (RPE) after induced injury. methods. Enriched HSCs/HPCs from green fluorescent protein (gfp) transgenic mice were transplanted into irradiated recipient mice to track bone marrow–derived cells. Physical damage was induced by breaching Bruch’s membrane and inducing vascular endothelial growth factor A (VEGFa) expression to promote neovascularization. RPE damage was also induced by sodium iodate injection (40 mg/kg) into wild-type or albino C57Bl/6 mice. Cell morphology, gfp expression, the presence of the Y chromosome, and the presence of melanosomes were used to determine whether the injured RPE was being repaired by the donor bone marrow. results. Injury to the RPE recruits HSC/HPC–derived cells to incorporate into the RPE layer and differentiate into an RPE phenotype. A portion of the HSCs/HPCs adopt RPE morphology, express melanosomes, and integrate into the RPE without cell fusion. conclusions. HSCs/HPCs can migrate to the RPE layer after physical or chemical injury and regenerate a portion of the damaged cell layer.

3 January 2005 in Journal of Clinical Investigation
Verified
Journal Article
Closed access
JBJason M. Butler
Jason M. Butler
SGSteven M. Guthrie
Steven M. Guthrie
MKMehmet Koc
Mehmet Koc
AAAqeela Afzal
Aqeela Afzal
SCSergio Caballero
Sergio Caballero
ESEdward W. Scott
Edward W. Scott
Diabetic retinopathy is the leading cause of blindness in working-age adults. It is caused by oxygen starvation in the retina inducing aberrant formation of blood vessels that destroy retinal architecture. In humans, vitreal stromal cell–derived factor–1 (SDF-1) concentration increases as proliferative diabetic retinopathy progresses. Treatment of patients with triamcinolone decreases SDF-1 levels in the vitreous, with marked disease improvement. SDF-1 induces human retinal endothelial cells to increase expression of VCAM-1, a receptor for very late antigen–4 found on many hematopoietic progenitors, and reduce tight cellular junctions by reducing occludin expression. Both changes would serve to recruit hematopoietic and endothelial progenitor cells along an SDF-1 gradient. We have shown, using a murine model of proliferative adult retinopathy, that the majority of new vessels formed in response to oxygen starvation originate from hematopoietic stem cell–derived endothelial progenitor cells. We now show that the levels of SDF-1 found in patients with proliferative retinopathy induce retinopathy in our murine model. Intravitreal injection of blocking antibodies to SDF-1 prevented retinal neovascularization in our murine model, even in the presence of exogenous VEGF. Together, these data demonstrate that SDF-1 plays a major role in proliferative retinopathy and may be an ideal target for the prevention of proliferative retinopathy.

18 May 2012 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
LPLiya Pi
Liya Pi
ASAnitha K. Shenoy
Anitha K. Shenoy
JLJianwen Liu
Jianwen Liu
SKSeungbum Kim
Seungbum Kim
NNNikole Nelson
Nikole Nelson
ESEdward W. Scott
Edward W. Scott
Blood vessels are formed during development and tissue repair through a plethora of modifiers that coordinate efficient vessel assembly in various cellular settings. Here we used the yeast 2‐hybrid approach and demonstrated a broad affinity of connective tissue growth factor (CCN2/CTGF) to C‐terminal cystine knot motifs present in key angiogenic regulators Slit3, von Willebrand factor, platelet‐derived growth factor‐B, and VEGF‐A. Biochemical characterization and histological analysis showed close association of CCN2/CTGF with these regulators in murine angiogenesis models: normal retinal development, oxygen‐induced retinopathy (OIR), and Lewis lung carcinomas. CCN2/CTGF and Slit3 proteins worked in concert to promote in vitro angiogenesis and downstream Cdc42 activation. A fragment corresponding to the first three modules of CCN2/CTGF retained this broad binding ability and gained a dominant‐negative function. Intravitreal injection of this mutant caused a significant reduction in vascular obliteration and retinal neovascularization vs . saline injection in the OIR model. Knocking down CCN2/CTGF expression by short‐hairpin RNA or ectopic expression of this mutant greatly decreased tumorigenesis and angiogenesis. These results provided mechanistic insight into the angiogenic action of CCN2/CTGF and demonstrated the therapeutic potential of dominant‐negative CCN2/CTGF mutants for antiangiogenesis.—Pi, L., Shenoy, A. K., Liu, J., Kim, S., Nelson, N., Xia, H., Hauswirth, W. W., Petersen, B. E., Schultz, G. S., Scott, E. W. CCN2/CTGF regulates neovessel formation via targeting structurally conserved cystine knot motifs in multiple angiogenic regulators. FASEB J. 26, 3365–3379 (2012). www.fasebj.org

6 September 2024 in Science Advances
Verified
Journal Article
Closed access
ALAlexander P. Ligocki
Alexander P. Ligocki
AVAugustine V. Vinson
Augustine V. Vinson
AYAnthony T. Yachnis
Anthony T. Yachnis
WDWilliam A. Dunn
William A. Dunn
DSDouglas E. Smith
Douglas E. Smith
ESEdward W. Scott
Edward W. Scott
Cerebrospinal fluid (CSF) is responsible for maintaining brain homeostasis through nutrient delivery and waste removal for the central nervous system (CNS). Here, we demonstrate extensive CSF flow throughout the peripheral nervous system (PNS) by tracing distribution of multimodal 1.9-nanometer gold nanoparticles, roughly the size of CSF circulating proteins, infused within the lateral cerebral ventricle (a primary site of CSF production). CSF-infused 1.9-nanometer gold transitions from CNS to PNS at root attachment/transition zones and distributes through the perineurium and endoneurium, with ultimate delivery to axoplasm of distal peripheral nerves. Larger 15-nanometer gold fails to transit from CNS to PNS and instead forms “dye-cuffs,” as predicted by current dogma of CSF restriction within CNS, identifying size limitations in central to peripheral flow. Intravenous 1.9-nanometer gold is unable to cross the blood-brain/nerve barrier. Our findings suggest that CSF plays a consistent role in maintaining homeostasis throughout the nervous system with implications for CNS and PNS therapy and neural drug delivery.

5 October 2011 in Experimental Eye Research
Verified
Journal Article
Closed access
HXHuiming Xia
Huiming Xia
MKMark Krebs
Mark Krebs
SKShalesh Kaushal
Shalesh Kaushal
ESEdward W. Scott
Edward W. Scott